G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma

[1]  M. Maniati,et al.  Shelterin Complex at Telomeres: Implications in Ageing , 2020, Clinical interventions in aging.

[2]  E. Dassi,et al.  hnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma , 2020, Nature Communications.

[3]  V. Band,et al.  Endogenous oxidized DNA bases and APE1 regulate the formation of G-quadruplex structures in the genome , 2020, Proceedings of the National Academy of Sciences.

[4]  L. Zou,et al.  Alternative lengthening of telomeres: from molecular mechanisms to therapeutic outlooks , 2020, Cell & Bioscience.

[5]  A. Antoccia,et al.  G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells , 2020, Genes.

[6]  Y. Heuzé,et al.  Impact of sampling strategies and reconstruction protocols in nasal airflow simulations in fossil hominins , 2018, Proceedings of the National Academy of Sciences.

[7]  O. Delattre,et al.  Does ATRX germline variation predispose to osteosarcoma? Three additional cases of osteosarcoma in two ATR-X syndrome patients , 2018, European Journal of Human Genetics.

[8]  R. Pearson,et al.  Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers , 2018, Proceedings of the National Academy of Sciences.

[9]  C. Miller,et al.  Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling , 2018, Nature Communications.

[10]  J. Maciejewski,et al.  IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors , 2018, Clinical Cancer Research.

[11]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[12]  C. Brennan,et al.  Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence , 2017, Nature Genetics.

[13]  J. Geigl,et al.  A novel mutation in ATRX associated with intellectual disability, syndromic features, and osteosarcoma , 2017, Pediatric blood & cancer.

[14]  Zepeng Zhang,et al.  A Cisplatin Derivative Tetra-Pt(bpy) as an Oncotherapeutic Agent for Targeting ALT Cancer , 2017, Journal of the National Cancer Institute.

[15]  S. Balasubramanian,et al.  Local epigenetic reprogramming induced by G-quadruplex ligands. , 2017, Nature chemistry.

[16]  Xiaowu Gai,et al.  Inherited germline ATRX mutation in two brothers with ATR‐X syndrome and osteosarcoma , 2017, American journal of medical genetics. Part A.

[17]  M. Gilbert,et al.  Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair. , 2017, Cancer research.

[18]  Jian Xian,et al.  CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours , 2017, Nature Communications.

[19]  Gregory A. Breuer,et al.  2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity , 2017, Science Translational Medicine.

[20]  J. Costello,et al.  Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process. , 2016, Cancer research.

[21]  R. Bjerkvig,et al.  Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. , 2016, Molecular cancer research : MCR.

[22]  Hiroshi Kimura,et al.  G-quadruplex structures mark human regulatory chromatin , 2016, Nature Genetics.

[23]  R. Bjerkvig,et al.  Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis , 2016, Molecular Cancer Research.

[24]  E. Goodall,et al.  Stalled replication forks within heterochromatin require ATRX for protection , 2016, Cell Death and Disease.

[25]  D. Ferguson,et al.  ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma , 2016, Science Translational Medicine.

[26]  H. Lipps,et al.  G-quadruplexes and their regulatory roles in biology , 2015, Nucleic acids research.

[27]  Junjiu Huang,et al.  The Daxx/Atrx Complex Protects Tandem Repetitive Elements during DNA Hypomethylation by Promoting H3K9 Trimethylation. , 2015, Cell stem cell.

[28]  D. Higgs,et al.  Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX , 2015, Nature Communications.

[29]  Steven J. M. Jones,et al.  Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. , 2015, The New England journal of medicine.

[30]  T. Jenuwein,et al.  ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes , 2015, Cell reports.

[31]  Ruslan Sadreyev,et al.  ATRX Directs Binding of PRC2 to Xist RNA and Polycomb Targets , 2014, Cell.

[32]  R. Pieper,et al.  Mutant IDH1-driven cellular transformation increases RAD51-mediated homologous recombination and temozolomide resistance. , 2014, Cancer research.

[33]  D. Higgs,et al.  ATRX Dysfunction Induces Replication Defects in Primary Mouse Cells , 2014, PloS one.

[34]  Caterina Giannini,et al.  Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  L. Deangelis,et al.  Glioblastoma and other malignant gliomas: a clinical review. , 2013, JAMA.

[36]  Jesse M. Platt,et al.  Detection of G-quadruplex DNA in mammalian cells , 2013, Nucleic acids research.

[37]  C. Brennan,et al.  Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine , 2013, Oncotarget.

[38]  D. Higgs,et al.  The chromatin remodeller ATRX: a repeat offender in human disease. , 2013, Trends in biochemical sciences.

[39]  T. Holland-Letz,et al.  ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis , 2013, Acta Neuropathologica.

[40]  Fang Wang,et al.  An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells , 2013, Science.

[41]  K. Shin‐ya,et al.  Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. , 2013, The Journal of clinical investigation.

[42]  Shankar Balasubramanian,et al.  G-Quadruplex structures are stable and detectable in human genomic DNA , 2013, Nature Communications.

[43]  Junjie Chen,et al.  Alpha Thalassemia/Mental Retardation Syndrome X-linked Gene Product ATRX Is Required for Proper Replication Restart and Cellular Resistance to Replication Stress* , 2013, The Journal of Biological Chemistry.

[44]  R. McLendon,et al.  Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas , 2012, Oncotarget.

[45]  W. Hahn,et al.  Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway , 2012, PLoS genetics.

[46]  Chris Sander,et al.  miR-34a Repression in Proneural Malignant Gliomas Upregulates Expression of Its Target PDGFRA and Promotes Tumorigenesis , 2012, PloS one.

[47]  B. Garcia,et al.  ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression. , 2012, Genes & development.

[48]  A. Viale,et al.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012, Nature.

[49]  Stephen P. Jackson,et al.  Small molecule-induced DNA damage identifies alternative DNA structures in human genes , 2012, Nature chemical biology.

[50]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[51]  Thomas Helleday,et al.  The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings , 2011, Molecular oncology.

[52]  R. McLendon,et al.  Altered Telomeres in Tumors with ATRX and DAXX Mutations , 2011, Science.

[53]  Katrin Paeschke,et al.  DNA Replication through G-Quadruplex Motifs Is Promoted by the Saccharomyces cerevisiae Pif1 DNA Helicase , 2011, Cell.

[54]  Stephen Neidle,et al.  Targeting G-quadruplexes in gene promoters: a novel anticancer strategy? , 2011, Nature Reviews Drug Discovery.

[55]  Steven J. M. Jones,et al.  ATR-X Syndrome Protein Targets Tandem Repeats and Influences Allele-Specific Expression in a Size-Dependent Manner , 2010, Cell.

[56]  S. De,et al.  DNA secondary structures and epigenetic determinants of cancer genome evolution , 2010, Nature Structural &Molecular Biology.

[57]  T. Helleday,et al.  Pathways of mammalian replication fork restart , 2010, Nature Reviews Molecular Cell Biology.

[58]  C. Baumann,et al.  Loss of Maternal ATRX Results in Centromere Instability and Aneuploidy in the Mammalian Oocyte and Pre-Implantation Embryo , 2010, PLoS genetics.

[59]  C. Allis,et al.  Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres , 2010, Proceedings of the National Academy of Sciences.

[60]  A. Hamiche,et al.  The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. , 2010, Genes & development.

[61]  R. Hannan,et al.  ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. , 2010, Genome research.

[62]  Amy Lin,et al.  Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. , 2009, Cancer research.

[63]  M. Foiani,et al.  The checkpoint response to replication stress. , 2009, DNA repair.

[64]  E. Gilson,et al.  Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway , 2009, Nucleic acids research.

[65]  E. Liu,et al.  Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements* , 2008, Journal of Biological Chemistry.

[66]  Joshua M. Korn,et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.

[67]  S. Balasubramanian,et al.  Selective recognition of a DNA G-quadruplex by an engineered antibody. , 2008, Biochemistry.

[68]  F. Dick,et al.  Loss of ATRX leads to chromosome cohesion and congression defects , 2008, The Journal of cell biology.

[69]  M. Mangelsdorf,et al.  The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis. , 2005, The Journal of clinical investigation.

[70]  N. Laperriere,et al.  Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[71]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[72]  M. Pflumm.  The role of DNA replication in chromosome condensation , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[73]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[74]  D. Higgs,et al.  Molecular-clinical spectrum of the ATR-X syndrome. , 2000, American journal of medical genetics.

[75]  N. Maizels,et al.  The Bloom’s Syndrome Helicase Unwinds G4 DNA* , 1998, The Journal of Biological Chemistry.

[76]  D P Byar,et al.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.

[77]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[78]  G. Fraedrich,et al.  Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.

[79]  R. McLendon,et al.  Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities. , 2018, Cancer research.

[80]  K. Shirahige,et al.  Chromatin immunoprecipitation protocol for mammalian cells. , 2014, Methods in molecular biology.

[81]  E. Kirkness,et al.  A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres , 2014, Journal of Neuro-Oncology.

[82]  J. Uhm.  IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype , 2012 .

[83]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[84]  A. Olshen,et al.  A Faster Circular Binary Segmentation Algorithm for the Analysis of Array Cgh Data , 2022 .